Friday, November 14, 2008
Marriott Waterfront Hotel
The University of Maryland Marlene and Stewart Greenebaum Cancer Center's (UMGCC) multidisciplinary breast cancer experts will present an update for primary care providers who care for patients with breast carcinoma. Patients are also welcome to attend the conference.
Breast cancer is the most common cancer among women in the United States, with an estimated 180,000 new cases diagnosed annually. A multi-disciplinary focus that entails prevention, diagnosis, and treatment has led to significant strides in the reduction of breast cancer incidence and mortality. Additionally, breast cancer management has become increasingly complex, requiring comprehensive assessment and review of multiple issues that include the role of genetic testing, imaging and breast magnetic resonance imaging, surgical and reconstructive options, and a variety of new adjuvant therapies.
It has become more evident that a multi-disciplinary team approach that involves a spectrum of breast experts is necessary to provide optimal care to patients. This team includes medical oncologists, breast radiologists, breast pathologists, surgical breast specialists, radiation oncologists and geneticists. The intended audience, which includes primary care physicians, general surgeons, medical oncologists, radiation oncologists, radiologists, nurse practitioners and other allied health care personnel, will be updated on the multi-disciplinary approach to diagnosis and treating breast cancer so that they can provide the best care to their patients and know when and how to refer patients to specialists.
Katherine H. Rak Tkaczuk, M.D.
Associate Professor of Medicine and Oncology
Director, Breast Evaluation and Treatment Program
University of Maryland Marlene and Stewart Greenebaum Cancer Center
$50 registration fee includes instruction materials, continental breakfast, lunch, CME certificate and complimentary parking.